
Dx Deals: Labcorp Continues Dealmaking with Incyte Asset Acquisition in Washington State
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
The majority of Labcorp’s revenue growth in the first quarter came from clinical lab acquisitions
Though the two national players have closed dozens of such deals over the past decade, much runway for new transactions apparently remains